CLEC10A and malignant colon neoplasm: Moreover, using a well characterized series of 386 colon cancer patients [23, 24], we now show for the first time that high expression of MGL ligands is an independent prognostic marker for stage III CRC patients, resulting in a significantly worse CRC-specific survival and higher recurrence rate.